ORIGINCLEAR, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ORIGINCLEAR, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.82M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.41M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $6.71M | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | $10.38M | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | $4.14M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $4.10M | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | $3.59M | May 21, 2021 |
| FY2019 | Dec 31, 2018 | $4.64M | May 29, 2020 |
| FY2018 | Dec 31, 2017 | $3.36M | Apr 25, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $3.36M | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $5.07M | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $954.5K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $166.2K | Apr 4, 2016 |
| FY2014 | Dec 31, 2013 | $140.5K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $588.2K | Apr 15, 2014 |
| FY2012 | Dec 31, 2011 | $180.0K | Apr 16, 2013 |
| FY2011 | Dec 31, 2010 | $45.5K | Apr 9, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.50M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $626.5K | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | $1.50M | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | $569.7K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $611.8K | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | $370.9K | May 21, 2021 |
| FY2019 | Dec 31, 2018 | $1.15M | May 29, 2020 |
| FY2018 | Dec 31, 2017 | $649.9K | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | $1.48M | Apr 17, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.32M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($18.18M) | Apr 13, 2026 |
| FY2022 | Dec 31, 2022 | ($10.79M) | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | ($2.12M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $13.26M | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | ($27.47M) | May 21, 2021 |
| FY2019 | Dec 31, 2018 | ($11.35M) | May 29, 2020 |
| FY2018 | Dec 31, 2017 | ($5.23M) | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | ($4.15M) | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($11.62M) | Mar 31, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.32M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($6.20M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($6.62M) | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | ($6.58M) | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | ($6.05M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($4.71M) | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | ($3.91M) | May 21, 2021 |
| FY2019 | Dec 31, 2018 | ($4.06M) | May 29, 2020 |
| FY2018 | Dec 31, 2017 | ($5.29M) | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | ($3.59M) | Apr 17, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2020 | $110.3K | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | $107.4K | May 21, 2021 |
| FY2019 | Dec 31, 2018 | $290.5K | May 29, 2020 |
| FY2018 | Dec 31, 2017 | $197.1K | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | $502.2K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $814.0K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.28M | Apr 4, 2016 |
| FY2014 | Dec 31, 2013 | $1.07M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $980.2K | Apr 15, 2014 |
| FY2012 | Dec 31, 2011 | $1.15M | Apr 16, 2013 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $5.74M | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | $5.23M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $4.94M | Apr 15, 2014 |
| FY2012 | Dec 31, 2011 | $4.21M | Apr 16, 2013 |
| FY2011 | Dec 31, 2010 | $3.82M | Apr 9, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.59M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($3.75M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($5.51M) | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | ($4.65M) | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | ($4.84M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($3.98M) | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | ($3.22M) | May 21, 2021 |
| FY2019 | Dec 31, 2018 | ($3.45M) | May 29, 2020 |
| FY2018 | Dec 31, 2017 | ($1.77M) | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | ($1.60M) | Apr 17, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $6.2K | May 29, 2020 |
| FY2019 | Dec 31, 2018 | $17.1K | May 29, 2020 |
| FY2018 | Dec 31, 2017 | $41.3K | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | $10.1K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $113.7K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $14.2K | Apr 4, 2016 |
| FY2014 | Dec 31, 2013 | $46.0K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $1.7K | Apr 15, 2014 |
| FY2012 | Dec 31, 2011 | $32.1K | Apr 16, 2013 |
| FY2011 | Dec 31, 2010 | $4.0K | Apr 9, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.75M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.99M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $3.14M | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | $6.35M | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | $4.20M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.33M | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | $1.34M | May 21, 2021 |
| FY2019 | Dec 31, 2018 | $1.36M | May 29, 2020 |
| FY2018 | Dec 31, 2017 | $1.36M | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | $1.78M | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.71M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $52.29M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $34.88M | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | $21.50M | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | $16.34M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $24.64M | Apr 7, 2022 |
| FY2019 | Dec 31, 2019 | $43.70M | May 29, 2020 |
| FY2019 | Dec 31, 2018 | $16.24M | May 29, 2020 |
| FY2018 | Dec 31, 2017 | $11.19M | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | $13.58M | Apr 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($26.02M) | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | ($22.32M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($29.65M) | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | ($44.57M) | May 21, 2021 |
| FY2020 | Dec 31, 2018 | ($16.62M) | May 21, 2021 |
| FY2019 | Dec 31, 2017 | ($9.83M) | May 29, 2020 |
| FY2018 | Dec 31, 2016 | ($11.80M) | Apr 25, 2019 |
| FY2017 | Dec 31, 2015 | ($12.75M) | Apr 17, 2018 |
| FY2016 | Dec 31, 2014 | ($7.20M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2013 | ($1.51M) | Apr 4, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2016 | $682.1K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $487.4K | Mar 31, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($155.71M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($137.39M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($119.22M) | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | ($108.97M) | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | ($98.18M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($94.02M) | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | ($107.28M) | May 21, 2021 |
| FY2019 | Dec 31, 2018 | ($79.81M) | May 29, 2020 |
| FY2018 | Dec 31, 2017 | ($68.46M) | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | ($63.23M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $828.0K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $371.5K | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $488.8K | Mar 31, 2025 |
| FY2020 | Dec 31, 2020 | $416.1K | May 21, 2021 |
| FY2020 | Dec 31, 2019 | $490.6K | May 21, 2021 |
| FY2020 | Dec 31, 2018 | $609.1K | May 21, 2021 |
| FY2019 | Dec 31, 2017 | $439.8K | May 29, 2020 |
| FY2018 | Dec 31, 2016 | $351.3K | Apr 25, 2019 |
| FY2017 | Dec 31, 2015 | $695.3K | Apr 17, 2018 |
| FY2016 | Dec 31, 2014 | $198.4K | Mar 31, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.62M | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | $2.02M | Mar 31, 2025 |
| FY2020 | Dec 31, 2020 | $3.12M | May 21, 2021 |
| FY2019 | Dec 31, 2019 | $3.43M | May 29, 2020 |
| FY2018 | Dec 31, 2018 | $75.0K | Apr 25, 2019 |
| FY2017 | Dec 31, 2017 | $2.81M | Apr 17, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | 0 | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | (12) | May 21, 2021 |
| FY2019 | Dec 31, 2018 | (50) | May 29, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 25, 2019 |
| FY2013 | Dec 31, 2013 | 0 | Apr 15, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Apr 15, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | 0 | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | (12) | May 21, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.62B | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | 1.67B | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | 1.40B | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | 1.01B | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | 306.88M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 65.05M | Apr 7, 2022 |
| FY2020 | Dec 31, 2019 | 4.85M | May 21, 2021 |
| FY2019 | Dec 31, 2018 | 875,244 | May 29, 2020 |
| FY2018 | Dec 31, 2017 | 112.89M | Apr 25, 2019 |
| FY2017 | Dec 31, 2016 | 21.43M | Apr 17, 2018 |